Melanoma Posts on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

Using long-term CT and PET/CT scans to identify metastatic recurrence in patients with resected melanoma.

Using long-term CT and PET/CT scans to identify metastatic recurrence in patients with resected melanoma.

Posted by on Feb 26, 2021 in Melanoma | 0 comments

In a nutshell This study evaluated how effective regular scanning is in identifying metastatic recurrence in patients with stage III melanoma that was surgically removed. Results showed that scanning every 6 or 12 months was reasonably good at detecting metastatic recurrence. Some background Melanoma is a form of aggressive skin cancer. Treatment...

Read More

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer

Posted by on Feb 26, 2021 in Melanoma | 0 comments

In a nutshell This study investigated the effectiveness and safety of stereotactic ablative radiation therapy (SABR) in the treatment of patients with oligometastatic (few metastases) cancer. The data showed that the use of SABR in these patients was associated with high overall survival and low toxicity. Some background Oligometastatic cancer (OMC)...

Read More

Controlling brain metastasis with localized radiotherapy.

Controlling brain metastasis with localized radiotherapy.

Posted by on Feb 17, 2021 in Melanoma | 0 comments

In a nutshell This study evaluated the impact of radiotherapy (RT) on controlling brain metastasis (BM). The study suggested that a single dose of RT was effective in controlling small BM. Larger BM could be controlled more effectively with multiple rounds of RT. Some background The spread of cancer from the original tumor to other parts of the...

Read More

Safety and effectiveness of different therapies after surgery for patients with resected melanoma.

Safety and effectiveness of different therapies after surgery for patients with resected melanoma.

Posted by on Jan 31, 2021 in Melanoma | 0 comments

In a nutshell This study compared how safe and effective are different therapies after surgery in patients with melanoma. This study showed that nivolumab had the best outcome for patients with melanoma following surgery. Some background Melanoma is a type of skin cancer. First line therapy for melanoma involves surgery to...

Read More

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Is radiosurgery in combination with other cancer therapies safe in patients with brain metastasis?

Posted by on Jan 31, 2021 in Melanoma | 0 comments

In a nutshell The aim of this study was to evaluate the safety of giving stereotactic radiosurgery (SRS) at the same time as other cancer treatments for patients who have brain metastasis. The study found that SRS given in combination with chemotherapy, immunotherapy, or targeted therapy was safe with low levels of side effects. Some background...

Read More

Evaluating the risk of heart-related side effects in patients treated with immune checkpoint inhibitors

Evaluating the risk of heart-related side effects in patients treated with immune checkpoint inhibitors

Posted by on Dec 31, 2020 in Melanoma | 0 comments

In a nutshell This study evaluated the risk of heart-related (HR) side effects in patients with melanoma treated with immune checkpoint inhibitors (ICI). Patients with melanoma were shown to have a higher risk of developing HR side effects when treated with ICIs. Some background ICIs are a type of cancer therapy used to treat a wide variety...

Read More

Does immune checkpoint therapy and radiotherapy combination improve response in treating brain metastasis from non-small cell lung cancer and melanoma?

Does immune checkpoint therapy and radiotherapy combination improve response in treating brain metastasis from non-small cell lung cancer and melanoma?

Posted by on Dec 30, 2020 in Melanoma | 0 comments

In a nutshell The study evaluated the timing of radiotherapy (RT) and immune-checkpoint therapy (ICT) on the outcomes of patients with brain metastasis (BrM) resulting from melanoma and non-small cell lung cancer (NSCLC). The authors found that RT and ICT given at the same time may improve response and delay recurrence in these patients. Some...

Read More

Searching for patients with EGFR-positive advanced tumors to trial an experimental treatment.

Searching for patients with EGFR-positive advanced tumors to trial an experimental treatment.

Posted by on Nov 22, 2020 in Melanoma | 0 comments

In a nutshell This trial is being carried out to assess the safety and effectiveness of an experimental drug called BCA101 alone and in combination with pembrolizumab (Keytruda) in advanced solid tumors that are EGFR-positive. The main outcomes to be measured are the occurrence of side effects and response to treatment. The details Advanced...

Read More